Oncology

FDA clears novel generic thyroid cancer treatment

February 11, 2020

FDA cleared the first generic sodium iodide product to treat hyperthyroidism and carcinoma of the thyroid.

Cancer-linked impurity found in heartburn drug

September 16, 2019

FDA is evaluating risks to patients.

Merck’s Keytruda snags another cancer indication

August 02, 2019

FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).

Top 6 Cancer Drug Trends

June 17, 2019

A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.

FDA approves cabozantinib for treatment-experienced patients with aggressive liver cancer

January 28, 2019

FDA approves cabozantinib to treat patients with hepatocellular carcinoma, a community in need of new therapeutic options.

FDA approves Tecentriq, Avastin combo for first-line treatment of lung cancer

December 18, 2018

A new non-small cell lung cancer (NSCLC) treatment is available to healthcare providers immediately.

FDA clears novel cancer treatments

December 04, 2018

Here are the top 2 novel cancer drugs cleared by the agency.

Top 3 new FDA approvals

October 01, 2018

Here are the top 3 new approvals from FDA.

Broader indication for prostate cancer drug could net billions of dollars

July 16, 2018

FDA’s approval of an expanded indication for a prostate cancer drug could net 2 pharmaceutical manufacturers billions of dollars.

Cancer risk found with common blood pressure med

July 16, 2018

Pharma makers are voluntarily recalling several drugs containing this active ingredient, used to treat high blood pressure and heart failure, since they may contain a carcinogen.